Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic Cancers
蛋白激酶 C (PKC)-θ 核转位的选择性靶向作用可减少间充质基因特征并重新激活免疫疗法耐药性和转移性癌症中的功能失调 CD8+ T 细胞
期刊:Cancers
影响因子:
doi:10.3390/cancers14061596
Jenny Dunn, Robert D McCuaig, Abel H Y Tan, Wen Juan Tu, Fan Wu, Kylie M Wagstaff, Anjum Zafar, Sayed Ali, Himanshu Diwakar, Jane E Dahlstrom, Elaine G Bean, Jade K Forwood, Sofiya Tsimbalyuk, Emily M Cross, Kristine Hardy, Amanda L Bain, Elizabeth Ahern, Riccardo Dolcetti, Roberta Mazzieri, Desmond
